Aadi Bioscience, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
November 09, 2022 at 08:20 am EST
Aadi Bioscience, Inc. reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported revenue was USD 4.25 million. Net loss was USD 14.47 million compared to USD 87.09 million a year ago. Basic loss per share from continuing operations was USD 0.68 compared to USD 9.17 a year ago.
For the nine months, revenue was USD 9.99 million compared to USD 0.12 million a year ago. Net loss was USD 46.6 million compared to USD 94.1 million a year ago. Basic loss per share from continuing operations was USD 2.21 compared to USD 19.37 a year ago.